Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, representing a minor update to the page's revision label. This change reflects an internal update to the page template or documentation without altering study details or user-visible content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag changed from v3.6.3 to v3.6.4, representing an updated page build. This update does not modify the study details or content shown to users.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating a software version update. This reflects an update to the site infrastructure rather than changes to study data or visible content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s revision tag was updated to v3.6.2, replacing the previous v3.6.0; this signals a minor update to the page’s documentation rather than substantive changes to study information.SummaryDifference0.1%

- Check58 days agoChange DetectedNew sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, along with a recruitment note stating No longer looking for participants. The Intervention / Treatment heading was reformatted to Intervention/Treatment and the page revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the page template or metadata. This change does not alter the study details or user-visible content.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.